Evidence map›Paper›PMID 41313179›Full record

ArticlemSystems2025

High-throughput chemical genomic screening: a step-by-step workflow from plate to phenotype.

Georgia Williams, Huda Ahmad, Susan Sutherland, James Haycocks, Sam Benedict, Adam J Hart, Hannah H Doherty, Rudi Sullivan, Micheal Alao, Xuyu Ma and 8 more

Abstract read
In one paragraph

Article in mSystems, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Georgia Williams *Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom.ORCID 0009-0003-0533-0383
Huda Ahmad *Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom.
Susan Sutherland *Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom.
James HaycocksBiosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
Sam BenedictBiosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
Adam J HartBiosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
Hannah H DohertyInstitute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom.
Rudi SullivanInstitute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom.
Micheal AlaoInstitute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom.
Xuyu MaBiosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
Qianhui XuBiosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
Jack BryantSchool of Pharmacy, University of Nottingham, Nottingham, United Kingdom.
Monika GlinkowskaDepartment of Bacterial Molecular Genetics, Faculty of Biology, University of Gdansk, Gdansk, Poland.
Peter BanksBiosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
Patrick MoynihanInstitute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom.
Mathew T MilnerLaboratory of Infectious Disease Epidemiology, KAUST Center of Excellence for Smart Health and Biological and Environmental Science and Engineering (BESE) Division, King Abdullah University of Science and Technology (KAUST), Thuwal, Kingdom of Saudi Arabia.ORCID 0009-0004-8653-4640
Danesh MoradigaravandLaboratory of Infectious Disease Epidemiology, KAUST Center of Excellence for Smart Health and Biological and Environmental Science and Engineering (BESE) Division, King Abdullah University of Science and Technology (KAUST), Thuwal, Kingdom of Saudi Arabia.ORCID 0000-0001-6652-5617
Manuel BanzhafInstitute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0002-4682-1037

Funding

Biotechnology and Biological Sciences Research CouncilBiotechnology and Biological Sciences Research Council BB/T00746X/1Darwin Trust of EdinburghKing Abdullah University of Science and Technology BAS/1/1108-01-01King Abdullah University of Science and Technology FCC/1/5932-01-03UK Research and Innovation MR/V027204/1
6 · The paper itself

Abstract

High-throughput chemical genomics uses phenotypic profiling of strain libraries under defined chemical and environmental conditions to identify gene functions. This approach enables the mapping of biological pathways and can potentially highlight drug targets. Chemical genomic data sets have been springboards for numerous hypothesis-driven research projects, with direct implications for antimicrobial resistance and clinical outcomes. High-throughput phenotypic profiles are valuable tools for enriching microbial sequence data with functional annotations and benefiting the broader scientific community. This work provides a step-by-step guide for conducting chemical genomics screens from start to finish.IMPORTANCEChemical genomic screening is a powerful systems biology approach for linking gene function to phenotype under diverse chemical and environmental stressors. However, its broader use in microbial research has been limited by the lack of standardized, reproducible workflows. Our study introduces a scalable, end-to-end protocol that integrates experimental, imaging, and computational steps into a cohesive framework for high-throughput screening across a range of microbial species. This enables researchers to generate consistent, high-quality phenotypic data suitable for large-scale analyses. The protocol supports systematic exploration of gene-environment interactions, microbial stress responses, and antimicrobial resistance. Its adaptability and troubleshooting guidance make it especially useful for groups working in microbiome research, synthetic biology, and microbial community studies. By bridging benchwork and computational analysis, this workflow expands the technical toolkit available to microbial systems biologists. Our work contributes to the development of robust methods for functional genomics and supports the core mission of mSystems to advance microbial systems biology.

Indexed as

GenomicsHigh-Throughput Screening AssaysPhenotypeWorkflowbioinformaticschemical genomicsgenomicssystems microbiology

Identifiers

PMID41313179
PMCPMC12710339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.